New Approach to Treat Preterm Labor
Author Information
Author(s): André Chollet, Enrico Gillio Tos, Rocco Cirillo
Primary Institution: Merck Serono, Geneva, Switzerland
Hypothesis
An orally active and selective FP antagonist may arrest labor and delay parturition in animal models.
Conclusion
The selective FP receptor antagonist AS604872 shows potential for treating preterm labor by delaying parturition.
Supporting Evidence
- AS604872 significantly reduced spontaneous uterine contractions in late-term pregnant rats.
- In pregnant mice, AS604872 delayed preterm birth caused by RU486 administration.
- The effect of AS604872 was dose-dependent, with significant increases in mean delivery time.
Takeaway
Scientists tested a new medicine that can help pregnant animals stay pregnant longer, which could help babies be born healthier.
Methodology
The study involved testing the effects of the FP receptor antagonist AS604872 on uterine contractions in pregnant rats and mice.
Limitations
The study was conducted in rodent models, which may not fully represent human physiology.
Participant Demographics
Pregnant rats and mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website